Background: Aerobic glycolysis promotes resistance against Aβ toxicity. Results: Increased LDHA and PDK1 expression attenuates mitochondrial activity and confers resistance to Aβ. These proteins are down-regulated in a transgenic Alzheimer disease (AD) mouse model, and PDK1 is decreased in AD brain. Conclusion: PDK and LDHA are central mediators of Aβ resistance. Significance: Drugs that augment aerobic glycolysis may enhance brain cell survival in AD patients. © 2012 by The American Society for Biochemistry and Molecular Biology, Inc
Citation: Zhang, L., Zhang, S., Maezawa, I., Trushin, S., Minhas, P., Pinto, M., . . . Trushina, E. ...
A key pathological feature of Alzheimer’s disease (AD) is the accumulation of the neurotoxic amyloid...
<div><p>Our study focused on the relationship between amyloid β 1–42 (Aβ), sphingosine kinases (SphK...
Alzheimer’s disease (AD) is characterized by deposition of the amyloid beta (Ab) peptide in the brai...
Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer\u27s disease (AD) is...
Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer's disease (AD) is cl...
Alzheimer’s disease is a progressive, neurodegenerative disorder characterized by the accumulation o...
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by amyloid plaques that are co...
This is the published version. Copyright 2011 by Journal of Alzheimer's Disease.Accumulation of amyl...
AbstractIt is frequently argued that both amyloid beta (Aβ) and oxidative stress are involved in the...
Alzheimer's disease (AD) and cancer proceed via one or more common molecular mechanisms: a metabolic...
Hypometabolism is a hallmark of Alzheimer\u27s disease (AD) and implicates a mitochondrial role in t...
Amyloid precursor protein (APP) and its extracellular domain, soluble APP alpha (sAPPα) play importa...
Mitochondria are key organelles for brain health. Rossi et al. show that, in different Alzheimer's d...
Evidence suggests that amyloid-beta (Aβ) protein is a key factor in the pathogenesis of Alzheimer's ...
Citation: Zhang, L., Zhang, S., Maezawa, I., Trushin, S., Minhas, P., Pinto, M., . . . Trushina, E. ...
A key pathological feature of Alzheimer’s disease (AD) is the accumulation of the neurotoxic amyloid...
<div><p>Our study focused on the relationship between amyloid β 1–42 (Aβ), sphingosine kinases (SphK...
Alzheimer’s disease (AD) is characterized by deposition of the amyloid beta (Ab) peptide in the brai...
Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer\u27s disease (AD) is...
Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer's disease (AD) is cl...
Alzheimer’s disease is a progressive, neurodegenerative disorder characterized by the accumulation o...
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by amyloid plaques that are co...
This is the published version. Copyright 2011 by Journal of Alzheimer's Disease.Accumulation of amyl...
AbstractIt is frequently argued that both amyloid beta (Aβ) and oxidative stress are involved in the...
Alzheimer's disease (AD) and cancer proceed via one or more common molecular mechanisms: a metabolic...
Hypometabolism is a hallmark of Alzheimer\u27s disease (AD) and implicates a mitochondrial role in t...
Amyloid precursor protein (APP) and its extracellular domain, soluble APP alpha (sAPPα) play importa...
Mitochondria are key organelles for brain health. Rossi et al. show that, in different Alzheimer's d...
Evidence suggests that amyloid-beta (Aβ) protein is a key factor in the pathogenesis of Alzheimer's ...
Citation: Zhang, L., Zhang, S., Maezawa, I., Trushin, S., Minhas, P., Pinto, M., . . . Trushina, E. ...
A key pathological feature of Alzheimer’s disease (AD) is the accumulation of the neurotoxic amyloid...
<div><p>Our study focused on the relationship between amyloid β 1–42 (Aβ), sphingosine kinases (SphK...